Status:

RECRUITING

Heart Rate Variability and Anxiety During Urinary Bladder Catheterization

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

ConvaTec Inc.

Vancouver Coastal Health

Conditions:

Spinal Cord Injuries

Urinary Bladder, Neurogenic

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

This is a prospective, randomised study investigating the physical and psychological experience of intermittent catheterization in adult individuals following spinal cord injury (SCI).

Detailed Description

Given that intermittent catheterization is the recommended method of bladder management in individuals with SCI, it is crucial that the potentially negative cardiovascular and psychological responses ...

Eligibility Criteria

Inclusion

  • Male or female, 18-70 years of age
  • Any chronic traumatic SCI with either motor sensory complete injury (AIS A/B, N=10) or motor sensory incomplete injury (AIS B/D, N=10).
  • At least 1 year post injury, and at least 6 months from any spinal surgery
  • Hand function sufficient to perform intermittent catheterization for management of urinary bladder drainage
  • Must provide informed consent and be able to understand and complete study-related questionnaires (must be able to understand and speak English or have access to an appropriate interpreter as judged by the investigator)
  • Willing and able to comply with clinic visit and study-related procedures

Exclusion

  • Signs or known current urinary tract infection, or other inflammatory conditions of bladder/urethra
  • Currently taking beta blockers or other medications that may affect heart rate
  • History of ureteral injury
  • History of any urinary diversion procedures, including but not limited to bladder augmentation, cystectomy, neo bladder, pouch reservoir, ileal conduit, Mitrofanoff appendicovesicostomy
  • For women of childbearing potential, currently pregnant
  • A member of the investigational team or his/her immediate family Presence of severe acute medical issue and use of any specific medication or treatment that, in the investigator's judgement, would adversely affect the participant's participation in the study

Key Trial Info

Start Date :

July 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT05380661

Start Date

July 15 2022

End Date

December 1 2024

Last Update

April 26 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Blusson Spinal Cord Centre

Vancouver, British Columbia, Canada, V5Z 1M9